Epigenetic regulation of chondrocyte catabolism and anabolism in osteoarthritis

Molecules and Cells

Volumn 38, Issue 8, 2015, Pages 677-684

  Kim, Hyeonkyeong ^a   Kang, Donghyun ^a   Cho, Yongsik ^a   Kim, Jin Hong ^a  

^a Seoul National University   (South Korea)

Author keywords

Cartilage; Chondrocytes; Epigenetics; Metabolism; Osteoarthritis

Indexed keywords

ADIPONECTIN; CATALASE; COLLAGENASE 3; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; GLUTATHIONE PEROXIDASE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 1BETA; LEPTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; REACTIVE OXYGEN METABOLITE; S ADENOSYLMETHIONINE; SIRTUIN 1; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR SOX9;

ARTICLE; BIOSYNTHESIS; CARTILAGE CELL; CARTILAGE DEGENERATION; CATABOLISM; CELL AGING; DNA METHYLATION; ENZYME ACTIVITY; EPIGENETICS; GENE CONTROL; HISTONE MODIFICATION; HUMAN; HYPERTENSION; MOLECULAR PATHOLOGY; NONHUMAN; OBESITY; OSTEOARTHRITIS; PATHOGENESIS; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION; ANIMAL; CHONDROCYTE; GENETIC EPIGENESIS; GENETICS; METABOLISM;

ANIMALS; CHONDROCYTES; EPIGENESIS, GENETIC; HUMANS; OSTEOARTHRITIS;

EID: 84949934623     PISSN: 10168478     EISSN: 02191032     Source Type: Journal    
DOI: 10.14348/molcells.2015.0200     Document Type: Article

References (108)

1. Blander, G, and Guarente, L. (2004). The Sir2 family of protein deacetylases. Ann. Rev. Biochem. 73, 417-435.
2. Bordone, L., Motta, M.C., Picard, F., Robinson, A., Jhala, U.S., Apfeld, J., McDonagh, T., Lemieux, M., McBurney, M., Szilvasi, A., et al. (2006). Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells. PLoS Biol. 4, e31.
3. Buckwalter, J.A., and Brown, T.D. (2004). Joint injury, repair, and remodeling: roles in post-traumatic osteoarthritis. Clin. Orthop. Relat. Res. 2004, 7-16.
4. Bui, C., Barter, M.J., Scott, J.L., Xu, Y., Galler, M., Reynard, L.N., Rowan, A.D., and Young, D.A. (2012). cAMP response element-binding (CREB) recruitment following a specific CpG demethylation leads to the elevated expression of the matrix metalloproteinase 13 in human articular chondrocytes and osteoarthritis. FASEB J. 26, 3000-3011.
5. Cai, L., and Tu, B.P. (2011). On acetyl-CoA as a gauge of cellular metabolic state. Cold Spring Harb. Symp. Quant. Biol. 76, 195-202.
6. Caito, S., Rajendrasozhan, S., Cook, S., Chung, S., Yao, H., Friedman, A.E., Brookes, P.S., and Rahman, I. (2010). SIRT1 is a redox-sensitive deacetylase that is post-translationally modified by oxidants and carbonyl stress. FASEB J. 24, 3145-3159.
7. Campion, J., Milagro, F.I., and Martinez, J.A. (2009). Individuality and epigenetics in obesity. Obesity Rev. 10, 383-392.
8. Carlo, M.D., Jr., and Loeser, R.F. (2003). Increased oxidative stress with aging reduces chondrocyte survival: correlation with intracellular glutathione levels. Arthritis. Rheum. 48, 3419-3430.
9. Carman, W.J., Sowers, M., Hawthorne, V.M., and Weissfeld, L.A. (1994). Obesity as a risk factor for osteoarthritis of the hand and wrist: a prospective study. Am. J. Epidemiol. 139, 119-129.
10. Chabane, N., Zayed, N., Afif, H., Mfuna-Endam, L., Benderdour, M., Boileau, C., Martel-Pelletier, J., Pelletier, J.P., Duval, N., and Fahmi, H. (2008). Histone deacetylase inhibitors suppress interleukin-1 beta-induced nitric oxide and prostaglandin E2 production in human chondrocytes. Osteoarthritis Cartilage 16, 1267-1274.
11. Chatterjee, T.K., Idelman, G, Blanco, V., Blomkalns, A.L., Piegore, M.G, Jr., Weintraub, D.S., Kumar, S., Rajsheker, S., Manka, D., Rudich, S.M., et al. (2011). Histone deacetylase 9 is a negative regulator of adipogenic differentiation. J. Biol. Chem. 286, 27836-27847.
12. Chen, T.H., Chen, L., Hsieh, M.S., Chang, C.P., Chou, D.T., and Tsai, S.H. (2006). Evidence for a protective role for adiponectin in osteoarthritis. Biochim. Biophys. Acta 1762, 711-718.
13. Chen, R., Dioum, E.M., Hogg, R.T., Gerard, R.D., and Garcia, J.A. (2011). Hypoxia increases sirtuin 1 expression in a hypoxia- inducible factor-dependent manner. J. Biol. Chem. 286, 13869-13878.
14. Conaghan, P.G., Vanharanta, H., and Dieppe, P.A. (2005). Is progressive osteoarthritis an atheromatous vascular disease? Ann. Rheum. Dis. 64, 1539-1541.
15. de Kreutzenberg, S.V., Ceolotto, G., Papparella, I., Bortoluzzi, A., Semplicini, A., Dalla Man, C., Cobelli, C., Fadini, GP., and Avogaro, A. (2010). Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms. Diabetes 59, 1006-1015.
16. de Ruijter, A.J., van Gennip, A.H., Caron, H.N., Kemp, S., and van Kuilenburg, A.B. (2003). Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem. J. 370, 737-749.
17. Dillon, C.F., Rasch, E.K., Gu, Q., and Hirsch, R. (2006). Prevalence of knee osteoarthritis in the United States: arthritis data from the Third National Health and Nutrition Examination Survey 1991-94. J. Rheumatol. 33, 2271-2279.
18. Duan, Y., Hao, D., Li, M., Wu, Z., Li, D., Yang, X., and Qiu, G. (2012). Increased synovial fluid visfatin is positively linked to cartilage degradation biomarkers in osteoarthritis. Rheumatol. Int. 32, 985-990.
19. Dumond, H., Presle, N., Terlain, B., Mainard, D., Loeuille, D., Netter, P., and Pottie, P. (2003). Evidence for a key role of leptin in osteoarthritis. Arthritis Rheum. 48, 3118-3129.
20. Dvir-Ginzberg, M., Gagarina, V., Lee, E.J., and Hall, D.J. (2008). Regulation of cartilage-specific gene expression in human chondrocytes by SirT1 and nicotinamide phosphoribosyltran-sferase. J. Biol. Chem. 283, 36300-36310.
21. Dvir-Ginzberg, M., Gagarina, V., Lee, E.J., Booth, R., Gabay, O., and Hall, D.J. (2011). Tumor necrosis factor alpha-mediated cleavage and inactivation of SirT1 in human osteoarthritic chondrocytes. Arthritis Rheum. 63, 2363-2373.
22. Fernandez-Tajes, J., Soto-Hermida, A., Vazquez-Mosquera, M.E., Cortes-Pereira, E., Mosquera, A., Fernandez-Moreno, M., Oreiro, N., Fernandez-Lopez, C., Fernandez, J.L., Rego-Perez, I., et al. (2014). Genome-wide DNA methylation analysis of articular chondrocytes reveals a cluster of osteoarthritic patients. Ann. Rheum. Dis. 73, 668-677.
23. Findlay, D.M. (2007). Vascular pathology and osteoarthritis. Rheumatology 46, 1763-1768.
24. Fujita, N., Matsushita, T., Ishida, K., Kubo, S., Matsumoto, T., Takayama, K., Kurosaka, M., and Kuroda, R. (2011). Potential involvement of SIRT1 in the pathogenesis of osteoarthritis through the modulation of chondrocyte gene expressions. J. Orthop. Res. 29, 511-515.
25. Furumatsu, T., and Asahara, H. (2010). Histone acetylation influences the activity of Sox9-related transcriptional complex. Acta Med. Okayama 64, 351-357.
26. Furumatsu, T., Tsuda, M., Yoshida, K., Taniguchi, N., Ito, T., Hashimoto, M., Ito, T., and Asahara, H. (2005). Sox9 and p300 cooperatively regulate chromatin-mediated transcription. J. Biol. Chem. 280, 35203-35208.
27. Gabay, O., Oppenhiemer, H., Meir, H., Zaal, K., Sanchez, C., and Dvir-Ginzberg, M. (2012). Increased apoptotic chondrocytes in articular cartilage from adult heterozygous SirT1 mice. Ann. Rheum. Dis. 71, 613-616.
28. Gabay, O., Sanchez, C., Dvir-Ginzberg, M., Gagarina, V., Zaal, K.J., Song, Y., He, X.H., and McBurney, M.W. (2013). Sirtuin 1 enzymatic activity is required for cartilage homeostasis in vivo in a mouse model. Arthritis Rheum. 65, 159-166.
29. Gagarina, V., Gabay, O., Dvir-Ginzberg, M., Lee, E.J., Brady, J.K., Quon, M.J., and Hall, D.J. (2010). SirT1 enhances survival of human osteoarthritic chondrocytes by repressing protein tyrosine phosphatase 1B and activating the insulin-like growth factor receptor pathway. Arthritis Rheum. 62, 1383-1392.
30. Gosset, M., Berenbaum, F., Salvat, C., Sautet, A., Pigenet, A., Tahiri, K., and Jacques, C. (2008). Crucial role of visfatin/pre-B cell colony-enhancing factor in matrix degradation and prostaglandin E2 synthesis in chondrocytes: possible influence on osteoarthritis. Arthritis Rheum. 58, 1399-1409.
31. Griffin, T.M., and Guilak, F. (2005). The role of mechanical loading in the onset and progression of osteoarthritis. Exerc. Sport Sci. Rev. 33, 195-200.
32. Griffin, T.M., Huebner, J.L., Kraus, V.B., and Guilak, F. (2009). Extreme obesity due to impaired leptin signaling in mice does not cause knee osteoarthritis. Arthritis Rheum. 60, 2935-2944.
33. Guilak, F. (2011). Biomechanical factors in osteoarthritis. Best practice & research. Clin. Rheumatol. 25, 815-823.
34. Haberland, M., Carrer, M., Mokalled, M.H., Montgomery, R.L., and Olson, E.N. (2010). Redundant control of adipogenesis by histone deacetylases 1 and 2. J. Biol. Chem. 285, 14663-14670.
35. Hart, D.J., Doyle, D.V., and Spector, T.D. (1995). Association between metabolic factors and knee osteoarthritis in women: the Chingford Study. J. Rheumatol. 22, 1118-1123.
36. Hashimoto, K., Oreffo, R.O., Gibson, M.B., Goldring, M.B., and Roach, H.I. (2009). DNA demethylation at specific CpG sites in the IL1B promoter in response to inflammatory cytokines in human articular chondrocytes. Arthritis Rheum. 60, 3303-3313.
37. Hashimoto, K., Otero, M., Imagawa, K., de Andres, M.C., Coico, J.M., Roach, H.I., Oreffo, R.O., Marcu, K.B., and Goldring, M.B. (2013). Regulated transcription of human matrix metalloproteinase 13 (MMP13) and interleukin-1 beta (IL1B) genes in chondrocytes depends on methylation of specific proximal promoter CpG sites. J. Biol. Chem. 288, 10061-10072.
38. Hatzivassiliou, G, Zhao, F., Bauer, D.E., Andreadis, C., Shaw, A.N., Dhanak, D., Hingorani, S.R., Tuveson, D.A., and Thompson, C.B. (2005). ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell 8, 311-321.
39. Heinegard, D., and Saxne, T. (2011). The role of the cartilage matrix in osteoarthritis. Nat. Rev. Rheumatol. 7, 50-56.
40. Higashiyama, R., Miyaki, S., Yamashita, S., Yoshitaka, T., Lindman, G, Ito, Y, Sasho, T., Takahashi, K., Lotz, M., and Asahara, H. (2010). Correlation between MMP-13 and HDAC7 expression in human knee osteoarthritis. Mod. Rheumatol. 20, 11-17.
41. Hong, S., Derfoul, A., Pereira-Mouries, L., and Hall, D.J. (2009). A novel domain in histone deacetylase 1 and 2 mediates repression of cartilage-specific genes in human chondrocytes. FASEB J. 23, 3539-3552.
42. Hong, E.H., Yun, H.S., Kim, J., Um, H.D., Lee, K.H., Kang, C.M., Lee, S.J., Chun, J.S., and Hwang, S.G (2011). Nicotinamide phosphoribosyltransferase is essential for interleukin-1 beta- mediated dedifferentiation of articular chondrocytes via SIRT1 and extracellular signal-regulated kinase (ErK) complex signaling. J. Biol. Chem. 286, 28619-28631.
43. Honsawek, S., and Chayanupatkul, M. (2010). Correlation of plasma and synovial fluid adiponectin with knee osteoarthritis severity. Arch. Med. Res. 41, 593-598.
44. Houard, X., Goldring, M.B., and Berenbaum, F. (2013). Homeostatic mechanisms in articular cartilage and role of inflammation in osteoarthritis. Curr. Rheumatol. Rep. 15, 375.
45. Huh, Y.H., Ryu, J.H., and Chun, J.S. (2007). Regulation of type II collagen expression by histone deacetylase in articular chondrocytes. J. Biol. Chem. 282, 17123-17131.
46. Iliopoulos, D., Malizos, K.N., and Tsezou, A. (2007). Epigenetic regulation of leptin affects MMP-13 expression in osteoarthritic chondrocytes: possible molecular target for osteoarthritis therapeutic intervention. Ann. Rheumatic Dis. 66, 1616-1621.
47. Imagawa, K., de Andres, M.C., Hashimoto, K., Itoi, E., Otero, M., Roach, H.I., Goldring, M.B., and Oreffo, R.O. (2014). Association of reduced type IX collagen gene expression in human osteoarthritic chondrocytes with epigenetic silencing by DNA hypermethylation. Arthritis Rheumatol. 66, 3040-3051.
48. Isabella Dalle-Donne, GA., Marina Carini, Roberto Colombo, Ranieri Rossi, Aldo Milzani (2006). Protein carbonylation, cellular dysfunction, and disease progre. J. Cell. Mol. Med. 10, 389-406.
49. Iyer, A., Fairlie, D.P., and Brown, L. (2012). Lysine acetylation in obesity, diabetes and metabolic disease. Immunol. Cell Biol. 90, 39-46.
50. Jallali, N., Ridha, H., Thrasivoulou, C., Underwood, C., Butler, P.E., and Cowen, T. (2005). Vulnerability to ROS-induced cell death in ageing articular cartilage: the role of antioxidant enzyme activity. Osteoarthritis Cartilage 13, 614-622.
51. Kaelin, W.G., Jr., and McKnight, S.L. (2013). Influence of metabolism on epigenetics and disease. Cell 153, 56-69.
52. Kang, E.H., Lee, Y.J., Kim, T.K., Chang, C.B., Chung, J.H., Shin, K., Lee, E.Y, Lee, E.B., and Song, Y.W. (2010). Adiponectin is a potential catabolic mediator in osteoarthritis cartilage. Arthritis Res. Ther. 12, R231.
53. Kim, K.I., Park, Y.S., and Im, G.I. (2013). Changes in the epigenetic status of the SOX-9 promoter in human osteoarthritic cartilage. J. Bone Miner. Res. 28, 1050-1060.
54. Kim, J.H., Jeon, J., Shin, M., Won, Y, Lee, M., Kwak, J.S., Lee, G., Rhee, J., Ryu, J.H., Chun, C.H., et al. (2014). Regulation of the catabolic cascade in osteoarthritis by the zinc-ZIP8-MTF1 axis. Cell 156, 730-743.
55. Kim, A.Y, Park, Y.J., Pan, X., Shin, K.C., Kwak, S.H., Bassas, A.F., Sallam, R.M., Park, K.S., Alfadda, A.A., Xu, A., et al. (2015). Obesity-induced DNA hypermethylation of the adiponectin gene mediates insulin resistance. Nat. Commun. 6, 7585.
56. Knudson, C.B., and Knudson, W. (2001). Cartilage proteoglycans. Semin. Cell Dev. Biol. 12, 69-78.
57. Kornaat, P.R., Sharma, R., van der Geest, R.J., Lamb, H.J., Kloppenburg, M., Hellio le Graverand, M.P., Bloem, J.L., and Watt, I. (2009). Positive association between increased popliteal artery vessel wall thickness and generalized osteoarthritis: is OA also part of the metabolic syndrome? Skeletal Radiol. 38, 1147-1151.
58. Koskinen, A., Juslin, S., Nieminen, R., Moilanen, T., Vuolteenaho, K., and Moilanen, E. (2011). Adiponectin associates with markers of cartilage degradation in osteoarthritis and induces production of proinflammatory and catabolic factors through mitogen-activated protein kinase pathways. Arthritis Res. Ther. 13, R184.
59. Kouzarides, T. (2007). Chromatin modifications and their function. Cell 128, 693-705.
60. Ku, J.H., Lee, C.K., Joo, B.S., An, B.M., Choi, S.H., Wang, T.H., and Cho, H.L. (2009). Correlation of synovial fluid leptin concentrations with the severity of osteoarthritis. Clin. Rheumatol. 28, 1431-1435.
61. Lago, R., Gomez, R., Otero, M., Lago, F., Gallego, R., Dieguez, C., Gomez-Reino, J.J., and Gualillo, O. (2008). A new player in cartilage homeostasis: adiponectin induces nitric oxide synthase type II and pro-inflammatory cytokines in chondrocytes. Osteoarthritis Cartilage 16, 1101-1109.
62. Lawrence, R.C., Felson, D.T., Helmick, C.G., Arnold, L.M., Choi, H., Deyo, R.A., Gabriel, S., Hirsch, R., Hochberg, M.C., Hunder, G. G., et al. (2008). Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 58, 26-35.
63. Lefebvre, V., Li, P., and de Crombrugghe, B. (1998). A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO J. 17, 5718-5733.
64. Ling, C., and Groop, L. (2009). Epigenetics: a molecular link between environmental factors and type 2 diabetes. Diabetes 58, 2718-2725.
65. Liu, Y, Dentin, R., Chen, D., Hedrick, S., Ravnskjaer, K., Schenk, S., Milne, J., Meyers, D.J., Cole, P., Yates, J., 3rd, et al. (2008). A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange. Nature 456, 269-273.
66. Loeser, R.F. (2013). Aging processes and the development of osteoarthritis. Curr. Opin. Rheumatol. 25, 108-113.
67. Maly, M.R., Costigan, P.A., and Olney, S.J. (2005). Contribution of psychosocial and mechanical variables to physical performance measures in knee osteoarthritis. Phys. Ther. 85, 1318-1328.
68. Marwick, J.A., Kirkham, P.A., Stevenson, C.S., Danahay, H., Giddings, J., Butler, K., Donaldson, K., Macnee, W., and Rahman, I. (2004). Cigarette smoke alters chromatin remodeling and induces proinflammatory genes in rat lungs. Am. J. Respir. Cell Mol. Biol. 31, 633-642.
69. Matsuzaki, T., Matsushita, T., Takayama, K., Matsumoto, T., Nishida, K., Kuroda, R., and Kurosaka, M. (2014). Disruption of Sirt1 in chondrocytes causes accelerated progression of osteoarthritis under mechanical stress and during ageing in mice. Ann. Rheumatic Dis. 73, 1397-1404.
70. Metallo, C.M., and Vander Heiden, M.G (2010). Metabolism strikes back: metabolic flux regulates cell signaling. Genes Dev. 24, 2717-2722.
71. Morano, A., Angrisano, T., Russo, G., Landi, R., Pezone, A., Bartollino, S., Zuchegna, C., Babbio, F., Bonapace, I.M., Allen, B., et al. (2014). Targeted DNA methylation by homology- directed repair in mammalian cells. Transcription reshapes methylation on the repaired gene. Nucleic Acids Res. 42, 804-821.
72. Mundermann, A., Dyrby, C.O., and Andriacchi, T.P. (2005). Secondary gait changes in patients with medial compartment knee osteoarthritis: increased load at the ankle, knee, and hip during walking. Arthritis Rheum. 52, 2835-2844.
73. Nagai, K., Matsushita, T., Matsuzaki, T., Takayama, K., Matsumoto, T., Kuroda, R., and Kurosaka, M. (2015). Depletion of SIRT6 causes cellular senescence, DNA damage, and telomere dysfunction in human chondrocytes. Osteoarthritis Cartilage 23, 1412-1420.
74. Nasu, Y, Nishida, K., Miyazawa, S., Komiyama, T., Kadota, Y, Abe, N., Yoshida, A., Hirohata, S., Ohtsuka, A., and Ozaki, T. (2008). Trichostatin A, a histone deacetylase inhibitor, suppresses synovial inflammation and subsequent cartilage destruction in a collagen antibody-induced arthritis mouse model. Osteoarthritis Cartilage 16, 723-732.
75. Nishikawa, K., Iwamoto, Y, Kobayashi, Y, Katsuoka, F., Kawaguchi, S., Tsujita, T., Nakamura, T., Kato, S., Yamamoto, M., Takayanagi, H., et al. (2015). DNA methyltransferase 3a regulates osteoclast differentiation by coupling to an S- adenosylmethionine-producing metabolic pathway. Nat. Med. 21, 281-287.
76. Oliveria, S.A., Felson, D.T., Cirillo, P.A., Reed, J.I., and Walker, A.M. (1999). Body weight, body mass index, and incident symptomatic osteoarthritis of the hand, hip, and knee. Epidemiology 10, 161-166.
77. Oppenheimer, H., Gabay, O., Meir, H., Haze, A., Kandel, L., Liebergall, M., Gagarina, V., Lee, E.J., and Dvir-Ginzberg, M. (2011). 75-kd sirtuin 1 blocks tumor necrosis factor alpha- mediated apoptosis in human osteoarthritic chondrocytes. Arthritis Rheum. 64, 718-728.
78. Oppenheimer, H., Kumar, A., Meir, H., Schwartz, I., Zini, A., Haze, A., Kandel, L., Mattan, Y, Liebergall, M., and Dvir-Ginzberg, M. (2013). Set7/9 impacts COL2A1 expression through binding and repression of SirT1 histone deacetylation. J. Bone Miner. Res. 29, 348-360.
79. Osoata, GO., Yamamura, S., Ito, M., Vuppusetty, C., Adcock, I.M., Barnes, P.J., and Ito, K. (2009). Nitration of distinct tyrosine residues causes inactivation of histone deacetylase 2. Biochem. Biophys. Res. Commun. 384, 366-371.
80. Otero, M., Lago, R., Lago, F., Reino, J.J., and Gualillo, O. (2005). Signalling pathway involved in nitric oxide synthase type II activation in chondrocytes: synergistic effect of leptin with interleukin-1. Arthritis Res. Ther. 7, R581-591.
81. Picard, F., Kurtev, M., Chung, N., Topark-Ngarm, A., Senawong, T., Machado De Oliveira, R., Leid, M., McBurney, M.W., and Guarente, L. (2004). Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 429, 771-776.
82. Poschl, E., Fidler, A., Schmidt, B., Kallipolitou, A., Schmid, E., and Aigner, T. (2005). DNA methylation is not likely to be responsible for aggrecan down regulation in aged or osteoarthritic cartilage. Ann. Rheumatic Dis. 64, 477-480.
83. Pradhan, S., and Esteve, P.-O. (2003). Mammalian DNA (cytosine- 5) methyltransferases and their expression. Clin. Immunol. 109, 6-16.
84. Puenpatom, R.A., and Victor, T.W. (2009). Increased prevalence of metabolic syndrome in individuals with osteoarthritis: an analysis of NHANES III data. Postgrad. Med. 121, 9-20.
85. Razin, A. (1998). CpG methylation, chromatin structure and gene silencing-a three-way connection. EMBO J. 17, 4905-4908.
86. Reynard, L.N., Bui, C., Canty-Laird, E.G, Young, D.A., and Loughlin, J. (2011). Expression of the osteoarthritis-associated gene GDF5 is modulated epigenetically by DNA methylation. Hum. Mol. Genet. 20, 3450-3460.
87. Roach, H.I., Yamada, N., Cheung, K.S., Tilley, S., Clarke, N.M., Oreffo, R.O., Kokubun, S., and Bronner, F. (2005). Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions. Arthritis Rheum. 52, 3110-3124.
88. Rodova, M., Lu, Q., Li, Y, Woodbury, B.G, Crist, J.D., Gardner, A. M., Yost, J.G, Zhong, X.B., Anderson, H.C., and Wang, J. (2010). Nfat1 regulates adult articular chondrocyte function through its age-dependent expression mediated by epigenetic histone methylation. J. Bone Miner. Res. 26, 1974-1986.
89. Ruiz-Romero, C., Calamia, V., Mateos, J.s., Carreira, V., Martinez- Gomariz, M., Fernandez, M.F., and Blanco, F.J. (2009). Mitochondrial dysregulation of osteoarthritic human articular chondrocytes analyzed by proteomics a decrease in mitochondrial superoxide dismutase points to a redox imbalance. Mol. Cell. Proteomics 8, 172-189.
90. Saito, T., Fukai, A., Mabuchi, A., Ikeda, T., Yano, F., Ohba, S., Nishida, N., Akune, T., Yoshimura, N., Nakagawa, T., et al. (2010). Transcriptional regulation of endochondral ossification by HIF-2alpha during skeletal growth and osteoarthritis development. Nat. Med. 16, 678-686.
91. Schipani, E., Ryan, H.E., Didrickson, S., Kobayashi, T., Knight, M., and Johnson, R.S. (2001). Hypoxia in cartilage: HIF-1 alpha is essential for chondrocyte growth arrest and survival. Genes Dev. 15, 2865-2876.
92. Schwer, B., and Verdin, E. (2008). Conserved metabolic regulatory functions of sirtuins. Cell Metab. 7, 104-112.
93. Sesselmann, S., Soder, S., Voigt, R., Haag, J., Grogan, S., and Aigner, T. (2009). DNA methylation is not responsible for p21WAF1/CIP1 down-regulation in osteoarthritic chondrocytes. Osteoarthritis Cartilage 17, 507-512.
94. Sterner, D.E., and Berger, S.L. (2000). Acetylation of histones and transcription-related factors. Microbiol. Mol. Biol. Rev. 64, 435-459.
95. Tateishi, K., Okada, Y, Kallin, E.M., and Zhang, Y. (2009). Role of Jhdm2a in regulating metabolic gene expression and obesity resistance. Nature 458, 757-761.
96. Troeberg, L., and Nagase, H. (2012). Proteases involved in cartilage matrix degradation in osteoarthritis. Biochim. Biophys. Acta 1824, 133-145.
97. Vega, R.B., Matsuda, K., Oh, J., Barbosa, A.C., Yang, X., Meadows, E., McAnally, J., Pomajzl, C., Shelton, J.M., Richardson, J.A., et al. (2004). Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 119, 555-566.
98. Wang, J., Gardner, B.M., Lu, Q., Rodova, M., Woodbury, B.G, Yost, J.G, Roby, K.F., Pinson, D.M., Tawfik, O., and Anderson, H.C. (2009). Transcription factor Nfat1 deficiency causes osteoarthritis through dysfunction of adult articular chondrocytes. J. Pathol. 219, 163-172.
99. Wellen, K.E., Hatzivassiliou, G, Sachdeva, U.M., Bui, T.V., Cross, J.R., and Thompson, C.B. (2009). ATP-citrate lyase links cellular metabolism to histone acetylation. Science 324, 1076-1080.
100. Wluka, A.E., Lombard, C.B., and Cicuttini, F.M. (2013). Tackling obesity in knee osteoarthritis. Nat. Rev. Rheumatol. 9, 225-235.
101. Yammani, R.R., and Loeser, R.F. (2012). Extracellular nicotinamide phosphoribosyltransferase (NAMPT/visfatin) inhibits insulin-like growth factor-1 signaling and proteoglycan synthesis in human articular chondrocytes. Arthritis Res. Ther. 14, R23.
102. Yang, S., Kim, J., Ryu, J.H., Oh, H., Chun, C.H., Kim, B.J., Min, A. H., and Chun, J.S. (2010). Hypoxia-inducible factor-2alpha is a catabolic regulator of osteoarthritic cartilage destruction. Nat. Med. 16, 687-693.
103. Yang, S., Ryu, J.H., Oh, H., Jeon, J., Kwak, J.S., Kim, J.H., Kim, G. A., Chun, C.H., and Chun, J.S. (2015). NAMPT (visfatin), a direct target of hypoxia-inducible factor-2alpha, is an essential catabolic regulator of osteoarthritis. Ann. Rheumatic Dis. 74, 595-602.
104. Yusuf, E., Ioan-Facsinay, A., Bijsterbosch, J., Klein-Wieringa, I., Kwekkeboom, J., Slagboom, P.E., Huizinga, T.W., and Kloppenburg, M. (2011). Association between leptin, adiponectin and resistin and long-term progression of hand osteoarthritis. Ann. Rheumatic Dis. 70, 1282-1284.
105. Zhong, H., May, M.J., Jimi, E., and Ghosh, S. (2002). The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol. Cell 9, 625-636.
106. Zhong, H.M., Ding, Q.H., Chen, W.P., and Luo, R.B. (2013). Vorinostat, a HDAC inhibitor, showed anti-osteoarthritic activities through inhibition of iNOS and MMP expression, p38 and ERK phosphorylation and blocking NF-kappaB nuclear translocation. Int. Immunopharmacol. 17, 329-335.
107. Zhuo, Q., Yang, W., Chen, J., and Wang, Y. (2012). Metabolic syndrome meets osteoarthritis. Nat. Rev. Rheumatol. 8, 729-737.
108. Zimmermann, P., Boeuf, S., Dickhut, A., Boehmer, S., Olek, S., and Richter, W. (2008). Correlation of COL10A1 induction during chondrogenesis of mesenchymal stem cells with demethylation of two CpG sites in the COL10A1 promoter. Arthritis Rheum. 58, 2743-2753.